Background/Objectives: Low energy availability (LEA) can cause impaired reproductive function, bone health issues, and suppressed immune function, and may result in decreased performance and overall health status. The purpose of this study was to investigate adaptions of body composition, blood status, resting metabolic rate, and endurance performance to gain more comprehensive insights into the symptoms of LEA and the adaptive effects in the athlete population (active women (n = 11) and men (n = 11)). Methods: Three treatments were defined as 45 (EA45, control), 30 (EA30), and 10 (EA10) kcal/kg FFM/day and randomly assigned. Pre- and post-intervention measurements were performed through blood sampling, bioelectrical impedance analysis, resting metabolic rate measurement, the oral glucose tolerance test (OGTT), and the incremental endurance test to exhaustion. Results: There was a significant reduction in body weight and fat mass in EA10 compared to EA45 (p ≤ 0.05). Blood serum levels were altered in triglyceride, uric acid, and creatinine concentrations in EA10 compared to EA45 (p ≤ 0.05). Furthermore, blood glucose was still accumulated after 120 min during OGTT in EA10 compared to EA45 (p ≤ 0.05). The respiratory exchange ratio was reduced during submaximal stages of the incremental treadmill test to exhaustion without influencing performance output after treatment EA10 (p ≤ 0.05). However, the resting metabolic rate did not change (p > 0.05). Conclusions: In conclusion, this short-term study indicates that energy restriction can lead to several metabolic-related adaptations, which suggests that the availability and regulation of glucose and fats are significantly influenced after only five days of LEA in physically active women and men. Future research should focus on longer exposures of LEA and sex-specific comparisons (including the menstrual cycle) on LEA symptoms.
16 January 2026 in Frontiers in Sports and Active Living
Introduction: Accurate detection of ovulation is essential for menstrual cycle-based training periodization for female athletes. Although body temperature tracking is a non-invasive method for this purpose, its reliability can vary depending on the measurement site and timing. This study aimed to compare the utility of different body temperature measurement methods and measurement times for ovulation detection. Methods: Seventeen recreationally active women tracked one menstrual cycle (October 2023 to February 2024) using continuous intravaginal core body temperature measurement as the reference method. Additional temperature measurements (sublingual, rectal and external ear) were taken at two points in time: 6 a.m. and upon waking. Ovulation was additionally confirmed using luteinizing hormone urinary tests. The post-ovulatory temperature increase was analyzed using both the validated Vollman method and the practical “three over six” rule for the four different methods and two different time points. Agreement of the measurement methods and times was assessed via Bland–Altman plots and concordance correlation coefficients. Results: The continuous intravaginal temperature sensor consistently identified ovulation with acceptable accuracy, detecting all ovulations and showing the largest temperature rise from follicular to luteal phase (0.31 ± 0.18 °C). Sublingual 6 a.m. measurements showed smaller temperature increases (0.17 ± 0.24 °C) and moderate agreement with the reference, whereas rectal (0.12 ± 0.21 °C) and external ear temperatures (0.22 ± 0.38 °C) exhibited higher variability and limited reliability. One cycle was confirmed as anovulatory and correctly identified by the intravaginal sensor. Discussion: The most reliable method for detecting ovulation in physically active women is continuous intravaginal temperature measurement. If this method is not available, a trained sublingual temperature measurement at a fixed time can be an acceptable, cost-effective alternative. All methods have their limitations.
Background: Understanding variations in the androgen profile is crucial for interpreting hormone data and developing cycle-based training strategies tailored to individual athlete needs. Therefore, this study investigates the androgen concentrations of elite female track and field athletes across various hormonal conditions, including natural eumenorrheic cycles, cycles under hormonal contraception, and cycles with menstrual disturbances. Methods: Using a prospective, longitudinal observational cohort design, 22 athletes (15 naturally cycling, 7 using hormonal contraception) were monitored for up to three consecutive cycles. The study utilised daily or near-daily urine sampling to analyse urinary steroid hormones (including testosterone and its metabolites) via gas chromatography-coupled mass spectrometry (GC-MS/MS). Results: Results demonstrated that in athletes with ovulatory menstrual cycles, urinary androgen concentrations, particularly testosterone, varied significantly by phase, peaking around the late follicular phase (lateFP: 7.35 ± 6.25 ng/mL). In contrast, athletes using combined oral contraceptives exhibited significantly suppressed androgen concentrations throughout the cycle compared to the natural cycle group, with mean urinary testosterone levels being notably lower (2.55 ± 2.91 ng/mL vs. 5.45 ± 4.31 ng/mL; p <0.001). These pill users also showed elevated concentrations of the inactive 5β-reductase metabolites (5β-androstanedione and 5β-androstanediol). Cycles with menstrual disturbances, such as luteal phase deficiency, also displayed altered and often lower concentrations of all urinary androgens. Conclusion: These findings highlight the significant influence of both endogenous menstrual cycle dynamics and exogenous hormone interventions on androgen availability, underscoring the necessity of considering the individual hormone status for performance optimization and athlete health management.